Fundraising Fox

Cytek Biosciences

NASDAQ: CTKB

Bellevue, US · Delaware corporation · 3 known investors

cytekbio.com ↗

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.

BiotechDeep TechHardwareHealthtechMedical Devicesin /cytek-biosciences@CytekBio

Founders & leadership

WJWenbin Jiang, Ph.D.
Wenbin Jiang, Ph.D.CEO and Chairman of the Board
MYMing Yan, Ph.D.
Ming Yan, Ph.D.Chief Technology Officer
MY
Ming YanExecutive Officer, Director
JZ
Jiecheng ZhangDirector
AP
Allen PoirsonDirector
AL
Andrew LevinDirector
FD
Feng DengDirector
JB
Jack BallDirector
WJ
Wenbin JiangExecutive Officer, Director

Investors · 3

3E Bioventures CapitalPalo Alto
F-Prime Capital PartnersCambridge · $3M – $10M
Northern Light Venture CapitalMenlo Park · $1.3M – $100M

Reported raises · per SEC filings

Form D private placements
▶$120MraisedNov 2020 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ming YanExecutive Officer, Director
  • Jiecheng ZhangDirector
  • Allen PoirsonDirector
  • Andrew LevinDirector
  • Feng DengDirector
  • Jack BallDirector
  • Wenbin JiangExecutive Officer, Director
Offering amount
$120M
Amount sold
$120M
Minimum investment
$1
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.